Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive. In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally ...
The long-awaited study, which was commissioned by the FDA in hopes of reducing racial bias, found results that contradict past research findings, leaving clinicians confused. Also: FDA Commissioner ...
LSD is a drug often associated with the counter-culture of the 1960s. But it is being studied as a promising therapy for ...
San Francisco’s UCSF is stepping into the national spotlight as one of several university medical centers testing whether a ...
UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...
The results from drugmaker Mindmed tested several doses of LSD in patients with moderate-to-severe generalized anxiety ...
Two later-stage trials investigating LSD for treating anxiety are due to conclude in 2026, which could lead to the drug being ...
WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback